Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McMaster University

$105,000.00

Investigating the impacts of maternal obesity-associated oxidative stress and intrauterine hypoxia on placental development and function

EF 2018-19

Résumé
Cardiovascular disease (CVD) and Type 2 Diabetes are leading causes of health-related disability in Canada and cause more than sixty percent of global chronic disease-related deaths annually. While lifestyle factors contribute to the development of these conditions, recent evidence has shown that adversity during fetal life can increase the risk of developing these metabolic diseases in adulthood. Maternal obesity during pregnancy is one such adverse condition and a strong predictor of childhood obesity, insulin resistance, and hypertension, which precedes diabetes and CVD. Current estimates place nearly half of women as being overweight or obese during pregnancy. While efforts have been made to intervene during pregnancy to reduce offspring disease risk induced by maternal obesity, diet and lifestyle interventions in the second half of pregnancy do little to improve these outcomes. Attention has now shifted towards the period surrounding conception and early embryonic development as a window of intervention. This research aims to understand how obesity alters the earliest stages of development and how this predisposes to chronic diseases later in life. The embryonic period consists of rapid development of the placenta, an organ which principally supports fetal development. Placental dysfunction is a leading cause of pregnancy-related complications and is believed to underlie the connection between maternal obesity and childhood metabolic disease. Obesity has been described as an inflammatory condition, and this elevated inflammation may disturb early placental development with consequences for fetal growth and postnatal health, however this area has remained largely unstudied. Understanding how early placental development is altered in the context of obesity will help to inform strategies to intervene during the periconceptional window and prevent both complications during pregnancy as well as the metabolic disease burden in the next generation.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
404151
Name
Bellissimo Christian J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating the impacts of maternal obesity-associated oxidative stress and intrauterine hypoxia on placental development and function
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Immunology; Obesity; Placenta; Pregnancy
Abstract
Cardiovascular disease (CVD) and Type 2 Diabetes are leading causes of health-related disability in Canada and cause more than sixty percent of global chronic disease-related deaths annually. While lifestyle factors contribute to the development of these conditions, recent evidence has shown that adversity during fetal life can increase the risk of developing these metabolic diseases in adulthood. Maternal obesity during pregnancy is one such adverse condition and a strong predictor of childhood obesity, insulin resistance, and hypertension, which precedes diabetes and CVD. Current estimates place nearly half of women as being overweight or obese during pregnancy. While efforts have been made to intervene during pregnancy to reduce offspring disease risk induced by maternal obesity, diet and lifestyle interventions in the second half of pregnancy do little to improve these outcomes. Attention has now shifted towards the period surrounding conception and early embryonic development as a window of intervention. This research aims to understand how obesity alters the earliest stages of development and how this predisposes to chronic diseases later in life. The embryonic period consists of rapid development of the placenta, an organ which principally supports fetal development. Placental dysfunction is a leading cause of pregnancy-related complications and is believed to underlie the connection between maternal obesity and childhood metabolic disease. Obesity has been described as an inflammatory condition, and this elevated inflammation may disturb early placental development with consequences for fetal growth and postnatal health, however this area has remained largely unstudied. Understanding how early placental development is altered in the context of obesity will help to inform strategies to intervene during the periconceptional window and prevent both complications during pregnancy as well as the metabolic disease burden in the next generation.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bellissimo, Christian J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~